Results: 8

For: economic evaluation AND systematic review

Is third-wave CBT good value?

thought-catalog-674419-unsplash

Chris Sampson summarises a systematic review on the economic impact of third-wave cognitive behavioural therapies, such as mindfulness-based cognitive therapy, acceptance and commitment therapy, extended behavioural activation, dialectical behaviour therapy, and mindfulness-based stress reduction.

[read the full story...]

Whiplash and neck pain: what’s most cost-effective?

Lateral_neck_X-ray_of_whiplash

GPs Tom Rowley and Michael Horsfield write their debut MSK Elf blog on a recent systematic review, which investigates the most cost-effective interventions for the management of whiplash-associated and neck pain-associated disorders.

[read the full story...]

Are Internet interventions cost-effective for mental health?

16844834832_f13124e85c_o

Chris Sampson looks at a systematic review of the economics of Internet interventions for common mental health problems such as depression and anxiety.

[read the full story...]

Art therapy for common mental health disorders

shutterstock_132622649

Chris Sampson reports on a new HTA systematic review and economic evaluation of art therapy for non-psychotic mental health disorders like depression, anxiety and phobias.

[read the full story...]

Away from crime and into treatment: diversion and aftercare for drug-using offenders

The review showed some evidence of publication bias

Can we steer drug-using offenders away from crime and into treatment? Chris Sampson explores a study of the cost-effectiveness of diversion and aftercare programmes for offenders using class A drugs.

[read the full story...]

Are treatments for bipolar disorder cost-effective?

shutterstock_177676103

Chris Sampson reports on a recent systematic review and critical appraisal of economic evaluations in bipolar disorder. He finds that there’s a pressing need for new studies, especially discrete event simulations.

[read the full story...]

Cytisine and varenicline for smoking cessation

shutterstock_125942273

Andrew Jones and Chris Sampson report on a systematic review and economic evaluation of cytisine and varenicline for smoking cessation, which finds that both drugs are clinically effective compared with placebo.

[read the full story...]

Lithium is less expensive than olanzapine in treatment-resistant depression, but has unclear clinical benefits

shutterstock_148197704

Treatment-resistant depression (TRD) still represents a challenge to psychiatric practice. Since patients have usually failed at least two antidepressants, drugs originally prescribed for other conditions are often tried as an augmentation (Souery er al., 2006). Amongst them, lithium (a mood-stabiliser used in the treatment of bipolar disorders) as well as atypical antipsychotics (AAPs, indicated for [read the full story…]